Orange Book product · Brand (NDA)
INOMAX
NITRIC OXIDE
At a glance
Dec 23, 1999
Approved
Brand (NDA)
Application
Not listed
TE code
20
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 23, 1999
26 yr 11 mo ago
Today
Patent 8282966 expires
Listed method-of-use patent (U-1286) expiration.
Jun 30, 2029
in 3 yr 1 mo
Patent 8293284 expires
Listed method-of-use patent (U-1286) expiration.
Jun 30, 2029
in 3 yr 1 mo
Patent 8431163 expires
Listed method-of-use patent (U-1286) expiration.
Jun 30, 2029
in 3 yr 1 mo
Patent 8795741 expires
Listed method-of-use patent (U-1286) expiration.
Jun 30, 2029
in 3 yr 1 mo
Patent 8846112 expires
Listed method-of-use patent (U-1286) expiration.
Jun 30, 2029
in 3 yr 1 mo
Patent 8282966*PED expires
Listed listed patent expiration.
Dec 30, 2029
in 3 yr 7 mo
Patent 8293284*PED expires
Listed listed patent expiration.
Dec 30, 2029
in 3 yr 7 mo
Patent 8431163*PED expires
Listed listed patent expiration.
Dec 30, 2029
in 3 yr 7 mo
Patent 8795741*PED expires
Listed listed patent expiration.
Dec 30, 2029
in 3 yr 7 mo
Patent 8846112*PED expires
Listed listed patent expiration.
Dec 30, 2029
in 3 yr 7 mo
Patent 8291904 expires
Listed drug product patent expiration.
Jan 06, 2031
in 4 yr 7 mo
Patent 8573209 expires
Listed drug product patent expiration.
Jan 06, 2031
in 4 yr 7 mo
Patent 8573210 expires
Listed drug product patent expiration.
Jan 06, 2031
in 4 yr 7 mo
Patent 8776794 expires
Listed drug product patent expiration.
Jan 06, 2031
in 4 yr 7 mo
Patent 8776795 expires
Listed drug product patent expiration.
Jan 06, 2031
in 4 yr 7 mo
Patent 8291904*PED expires
Listed listed patent expiration.
Jul 06, 2031
in 5 yr 1 mo
Patent 8573209*PED expires
Listed listed patent expiration.
Jul 06, 2031
in 5 yr 1 mo
Patent 8573210*PED expires
Listed listed patent expiration.
Jul 06, 2031
in 5 yr 1 mo
Patent 8776794*PED expires
Listed listed patent expiration.
Jul 06, 2031
in 5 yr 1 mo
Patent 8776795*PED expires
Listed listed patent expiration.
Jul 06, 2031
in 5 yr 1 mo
Pharmaceutical detail
Active ingredient
NITRIC OXIDE
Strength
100PPM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
GAS
Route
INHALATION
TE code
Not listed
Application
NDA 020845
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (20)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8282966 | Jun 30, 2029 | in 3 yr 1 mo | U-1286 |
| 8293284 | Jun 30, 2029 | in 3 yr 1 mo | U-1286 |
| 8431163 | Jun 30, 2029 | in 3 yr 1 mo | U-1286 |
| 8795741 | Jun 30, 2029 | in 3 yr 1 mo | U-1286 |
| 8846112 | Jun 30, 2029 | in 3 yr 1 mo | U-1286 |
| 8282966*PED | Dec 30, 2029 | in 3 yr 7 mo | |
| 8293284*PED | Dec 30, 2029 | in 3 yr 7 mo | |
| 8431163*PED | Dec 30, 2029 | in 3 yr 7 mo | |
| 8795741*PED | Dec 30, 2029 | in 3 yr 7 mo | |
| 8846112*PED | Dec 30, 2029 | in 3 yr 7 mo | |
| 8291904 | Jan 06, 2031 | in 4 yr 7 mo | ProductU-1226 |
| 8573209 | Jan 06, 2031 | in 4 yr 7 mo | Product |
| 8573210 | Jan 06, 2031 | in 4 yr 7 mo | ProductU-1453 |
| 8776794 | Jan 06, 2031 | in 4 yr 7 mo | ProductU-1226 |
| 8776795 | Jan 06, 2031 | in 4 yr 7 mo | ProductU-1226 |
| 8291904*PED | Jul 06, 2031 | in 5 yr 1 mo | |
| 8573209*PED | Jul 06, 2031 | in 5 yr 1 mo | |
| 8573210*PED | Jul 06, 2031 | in 5 yr 1 mo | |
| 8776794*PED | Jul 06, 2031 | in 5 yr 1 mo | |
| 8776795*PED | Jul 06, 2031 | in 5 yr 1 mo |
